Washington Biotechnology
  • In Vivo CRO Services
    • Autoimmune & Inflammatory Diseases
      • Multiple Sclerosis
      • Gout
      • Inflammatory Bowel Disease (IBD)
      • Dermatitis (Contact)
      • Lupus
      • Nephritis
      • Pancreatitis
      • Hepatitis
      • Psoriasis
      • Pulmonary Fibrosis
      • Diabetes
      • General Inflammation Assessment
      • Acute Choleostasis Model
    • Rheumatoid Arthritis
      • Collagen-Induced Arthritis Model
      • Adjuvant-Induced Arthritis Model
      • Carrageenan Air Pouch Model
      • Zymosan Air Pouch Model
      • Pristane-Induced Arthritis Model
      • Ovalbumin-Induced Arthritis Model
      • SCW PG-PS 10S Rat Model
      • Arthritis Combo Testing: Rodent/Rabbit
    • Cancer
      • WBI Cell Lines for Cancer Models
      • Xenograft, Orthotopic & Syngeneic Models
    • Bacterial Infection
      • MRSA Model
      • Listeria Model
    • Pain Studies
      • Formalin Test (Chemical Sensitivity)
    • Pharmacokinetics and Toxicity
      • Pharmacokinetics (PK)
      • Toxicity and MTD Studies
    • Support Services
      • In Vitro Compound Screening for Anti-inflammatory Activity
    • WBI Project Management
  • About Us
  • What's New
  • Contact Us
  • Sitemap
  • Careers
  • In Vivo CRO Services
    • Autoimmune & Inflammatory Diseases
    • Rheumatoid Arthritis
      • Collagen-Induced Arthritis Model
      • Adjuvant-Induced Arthritis Model
      • Carrageenan Air Pouch Model
      • Zymosan Air Pouch Model
      • Pristane-Induced Arthritis Model
      • Ovalbumin-Induced Arthritis Model
      • SCW PG-PS 10S Rat Model
      • Arthritis Combo Testing: Rodent/Rabbit
    • Cancer
    • Bacterial Infection
    • Pain Studies
    • Pharmacokinetics and Toxicity
    • Support Services
    • WBI Project Management
  • About Us
  • What's New
  • Contact Us
  • Sitemap
  • Careers

Carrageenan Air Pouch Model

​

 

The Air Pouch Model in rats or mice measures anti-inflammatory activity of test compounds and may provide insight into the mechanism of action.

An Air Pouch is produced simply by subcutaneous injection of sterile air into the back of a mouse or rat. The formation of an air pouch provides a localized environment for study of inflammation and cellular response because the pouch has a lining morphologically similar to the synovium. It avoids the technical difficulties of sampling the true synovium in a knee joint. Directly administering an inflammatory stimulus to a knee joint and subsequently collecting inflammatory exudates is technically very challenging to perform without causing damage leading to inflammation.

With the Air Pouch Model large volumes of inflammatory exudates can be collected with relative ease. Injection of carrageenan solution or other inflammatory irritant (i.e. LPS, bradykinin), into the air pouch causes an inflammatory reaction characterized by:

•          infiltration of white blood cells

•          increase in exudate volume

•          production of biochemical mediators such as cytokines, leukotrienes and prostaglandins

A reduction in carrageenan-induced inflammation is used to measure efficacy of a test compound administered prior to carrageenan treatment.

In addition to an assessment of anti-inflammatory activity of a test compound, the Air Pouch Model may provide insight into the mechanism of action. The inflammatory response involves multiple interactions between signaling pathways which have developed a high degree of redundancy.

 

Carrageenan Air Pouch Model

Through differential cell analysis of inflammatory exudates, this unique  model identifies possible cell types suppressed by the test compound and hence potential underlying mechanism of drug action.

 

Species SD rat or Balb/c mouse
Study Duration 6 days
Readouts
  • Exudate volume
  • Cell counts: total wbc and differentials
Optional
  • Immunohistochemical staining of air pouch tissue samples for detection of inflammatory cell infiltration
  • Cytokine assays on exudate samples

 

 

An example of the effect of pretreatment with indomethacin in the 6-day rat air pouch model (1% carrageenan)

An example of the effect of pretreatment with IP indomethacin in the 6-day mouse air pouch model (3% carrageenan)

Contact Us
Request a Quote
What's New?
Read Our Newsletter

© Washington Biotechnology Inc., 2014. All Rights Reserved.
Built by Biz-Zone